Conference Coverage

Benefits vs Risks of Cancer Screening

Michael J. Kelley, MD, discusses concepts and inherent biases associated with lung cancer screening trials and how VHA is applying trial data to clinical practice.


 

References

The VA is conducting a limited lung cancer screening pilot at 8 VA hospitals to better understand how to implement screening nationwide. Through this pilot, VA is attempting to identify the right physicians to offer screening during the course of routine care; determine the uptake of screening and what resources will be needed to meet the demand; establish appropriate screening and follow-up with accuracy, efficiency, and safety; and answer whether the overall outcomes of patients with early-stage cancer (especially those who are older with comorbid conditions) benefit from early detection.

Among many of the World Health Organization’s screening principles, Michael J. Kelley, MD, called attention to the organization’s concern that the natural history of the condition should be adequately understood. “I think the key word there is adequately,” said Dr. Kelley. “When you look at the development of disease from precursor lesions, do we really understand what is going to become a cancer that causes disease as opposed to that which is a cancer only to the pathologist?”

Recommended Reading

Palliative Radiotherapy for the Management of Metastatic Cancer
Federal Practitioner
Prostate Cancer in Seniors, Part 1: Epidemiology, Pathology, and Screening
Federal Practitioner
ELCC: Survey reveals worldwide underuse of EGFR-mutation testing
Federal Practitioner
Multidisciplinary Treatment of Esophageal Cancer
Federal Practitioner
Update on Advanced Prostate Cancer
Federal Practitioner
AVAHO Readies for 2015 Meeting in Washington
Federal Practitioner
Should Geographic Location Impact Cancer Treatment?
Federal Practitioner
Joao Ascensao Talks AVAHO 2015
Federal Practitioner
Systems Automation for Cancer Surveillance
Federal Practitioner
Major Cancer Death Rates Are Down
Federal Practitioner